Gamida Cell Ltd GMDA:OTCPK

*Data is delayed | Exchange | USD
Last | undefined
()
52 week range
0.00 - 0.00
Loading...
  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date06/05/23
  • 52 Week Low0.00
  • 52 Week Low Date04/01/24

Key Stats

  • Market Cap-
  • Shares Out154.05M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-

KEY STATS

  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date06/05/23
  • 52 Week Low0.00
  • 52 Week Low Date04/01/24
  • Market Cap-
  • Shares Out154.05M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.66
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-70.619M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)18.50%
  • Net Margin (TTM)-3,531.17%
  • Debt To Equity (MRQ)-2,697.39%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gamida Cell Ltd

 

Content From Our Affiliates

Profile

MORE
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and potency. The following are the Company's clinical pipeline products: Omidubicel...
Shawn Tomasello
Independent Non-Executive Chairwoman of the Board
Abigail Jenkins
President, Chief Executive Officer, Director
Terry Coelho
Chief Financial Officer
Address
PO Box 34670
Jerusalem
91340
Israel